InflaRx

-$0.01 (-0.36%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.

About IFRX

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2.

CEO
Niels Christoph Riedemann
Employees
49
Headquarters
Jena, Thueringen
Founded
2007

IFRX Key Statistics

Market Cap
121.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
485.67K
High Today
$2.80
Low Today
$2.71
Open Price
$2.78
Volume
92.94K
52 Week High
$6.88
52 Week Low
$2.23

IFRX Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure